Q4 2025 Earnings Call Transcript September 23, 2025 Operator: Greetings. Welcome to the Aytu BioPharma, Inc. report for fiscal 2025 full year and fourth quarter operational and financial results on ...

CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this biotech stock.

Andrew Childs is a professor in the Department of Computer Science and the Institute for Advanced Computer Studies (UMIACS) at the University of Maryland, College Park. He serves as interim director ...

A couple hundred nuclear energy industry officials, along with two western state governors, a Trump administration official and a member of the U.S. Nuclear Regulatory Commission, gathered Monday at ...

Companies are increasingly using algorithmic management tools as a way to maximize the exploitation of workers. The power that managers gain from these tools can seem daunting, but there are ...